QUODD

Insider Transactions last 24 months for Oncolytics Biotech Inc. - NSDQ: ONCY

Transactions
All	Buy	Sell	Option Exercise

Filer's Name	Relationship/ Title	Trans. Date	Trans. Type	Ownership Type	Security Type	Shares	Price	Trans. Value	Total Shares Owned
Kelly Jared	Chief Executive Officer	03/12/2026	AP	Direct	COM	5,050	$0.96	$4,848.00	114,050
Parsons James T.	Director	03/11/2026	AP	Direct	COM	10,000	$1.03	$10,300.00	41,849
Andrews Patricia S	Director	02/12/2026	AP	Direct	COM	35,400	$0.86	$30,291.78	78,128
Brown Deborah Margaret	Director	02/12/2026	AP	Direct	COM	25,000	$0.85	$21,240.00	109,851
Hagerman Allison	VP, Product Development	02/12/2026	AP	Direct	COM	10,000	$0.83	$8,298.00	115,059
Heineman Thomas Charles	Chief Medical Officer	02/12/2026	AP	Direct	COM	12,132	$0.83	$10,033.16	282,818
Kelly Jared	Chief Executive Officer	02/12/2026	AP	Direct	COM	29,500	$0.84	$24,839.00	109,000
Look Kirk	Chief Financial Officer	02/12/2026	AP	Direct	COM	12,000	$0.84	$10,104.00	287,515
Pisano Wayne	Director	02/12/2026	AP	Direct	COM	30,000	$0.84	$25,338.00	492,414
Seizinger Bernd R.	Director	02/12/2026	AP	Direct	COM	40,000	$0.85	$33,864.00	566,991
Aromando Andrew	Chief Business Officer	02/11/2026	AP	Direct	COM	29,600	$0.86	$25,417.52	55,100
Kelly Jared	Chief Executive Officer	02/11/2026	AP	Direct	COM	5,600	$0.84	$4,681.60	79,500
Seizinger Bernd R.	Director	02/11/2026	AP	Direct	COM	60,000	$0.83	$49,590.00	526,991
Seizinger Bernd R.	Director	01/16/2026	AP	Direct	COM	100,000	$1.04	$103,770.00	466,991

1 You are at page 1 of 1 pages

Transaction Type Key First letter: A = Acquired, D = Disposed Second letter: A = Grant, award or other acquisition pursuant to Rule 16b-3(d) C = Conversion of derivative security \| D = Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) \| E = Expiration of short derivative position \| F = Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3. \| G = Gift \| H = Expiration (or cancellation) of long derivative position with value received \| I = Discretionary transaction in accordance with Rule 16b-3(f) \| J = Other \| L = Small acquisition under Rule 16a-6 \| M = Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 \| O = Exercise of out-of-the-money derivative security \| P = Open market or private purchase \| S = Open market or private sale \| U = Disposition pursuant to a tender of shares in a change of control transaction \| W = Acquisition or disposition by will or the laws of descent and distribution \| X = Exercise of in-the-money or at-the-money derivative security \| Z = Deposit into or withdrawal from voting trust		Send to Excel

Transaction Type Key
First letter: A = Acquired, D = Disposed
Second letter:
A = Grant, award or other acquisition pursuant to Rule 16b-3(d) C = Conversion of derivative security | D = Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | E = Expiration of short derivative position | F = Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3. | G = Gift | H = Expiration (or cancellation) of long derivative position with value received | I = Discretionary transaction in accordance with Rule 16b-3(f) | J = Other | L = Small acquisition under Rule 16a-6 | M = Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | O = Exercise of out-of-the-money derivative security | P = Open market or private purchase | S = Open market or private sale | U = Disposition pursuant to a tender of shares in a change of control transaction | W = Acquisition or disposition by will or the laws of descent and distribution | X = Exercise of in-the-money or at-the-money derivative security | Z = Deposit into or withdrawal from voting trust

Send to Excel